Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × glucarpidase × Clear all

NCT05022797 2024-05-13

Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS

Phase 2 Terminated

Lymphoma, Large B-Cell, Diffuse, Drug-Related Side Effects and Adverse Reactions